Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease

B CathWorks FFRangio® System employs drug-free, wire-free technology for comprehensive physiological assessment GALWAY, Ireland, April 20, 2026 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare…
posteditor
posteditor
Articles: 16137